
Survival for testicular cancer has risen by almost 30 per cent in the last 40 years in Britain, with nearly all men now beating the disease, according to figures published by Cancer Research UK on Monday. These latest figures show that more than 96 per cent of men now survive testicular cancer in the country, compared with less than 70 per cent in the 1970s. These improvements are largely thanks to the development of new drugs, especially the drug cisplatin. As he most common cancer in men aged 15-49, around 2,300 cases of testicular cancer are diagnosed each year in the Britain. "This is a shining example of what we can achieve through dedicated research." Dr Harpal Kumar, Cancer Research UK's chief executive, said: "It's only by doing more research that we can bring forward the day when we are able to beat all types of cancer." The most common symptom of testicular cancer is a lump or swelling in one of the testicles, according to experts at Cancer Research UK, although most lumps in the testicle won't turn out to be cancer, it's important to get symptoms checked out as early as possible as this gives the best chance of cure.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor